IP Library Granted Patent US 7,015,353
Granted Patent B2
US 7,015,353 · App. 10/819,693 · Granted Mar 21, 2006

Process for the production of 9-(Z)-retinoic acid

Assignee: Hoffmann-La Roche Inc.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,015,353
App. No.
10/819,693
Granted
Mar 21, 2006
Kind
B2
Abstract

A process for the production of 9-(Z)-retinoic acid is described which comprises reacting an alkali metal salt of 3-methyl-4-oxocrotonic acid with a C 15 -triphenyl-phosphonium salt. 9-(Z)-retinoic acid is used in the treatment of dermatological diseases.

Claims (25)

1. A process for the preparation of 9-(Z)-retinoic acid, comprising reacting an alkali metal salt of 3-methyl-4-oxocrotonic acid of the formula

wherein M stands for sodium or potassium, with the (Z)-isomer of a C 15 -triphenyl phosphonium salt of the formula

wherein X stands for a halogen, in the presence of a base.

2. The process according to claim 1 , wherein the alkali metal salt of methyl-4-oxocrotonic acid is prepared in situ from an alkyl-3-methyl-4-oxocrotonate which is hydrolyzed in the presence of an alkali hydroxide.

3. The process according to claim 2 , wherein M stands for potassium, and the potassium salt of methyl-4-oxocrotonic acid is prepared in situ from ethyl-3-methyl-4-oxocrotonate which is hydrolyzed in the presence of potassium hydroxide.

4. The process according to claim 1 , wherein X − in formula II is chlorine.

5. The process according to claim 1 , wherein the (Z)-isomer of a C 15 -triphenyl phosphonium salt is isolated from an isomeric mixture of the (Z)-isomer and the (E)-isomer, comprising the steps:

a) extracting a concentrate of the isomeric mixture with methylene chloride,

b) taking up the organic phase in ethylacetate/n-butanol,

c) distilling off ethylacetate/methylene chloride,

d) replacing the distilled amount with ethylactetate, and

e) crystallizing out the (Z)-isomer.

6. The process according to claim 1 , wherein the reaction is performed at a temperature of from −15° C. to 15° C.

7. The process according to claim 1 , wherein the reaction is performed in the presence of a lower alcohol.

8. The process according to claim 1 , wherein the base is an alkali hydroxide.

9. The process according to claim 8 , wherein the base is potassium hydroxide.

10. The process according to claim 1 , wherein the process further comprises:

a) extracting the alkali metal salt of 3-methyl-4-oxocrotonic acid and (Z)-isomer of a C 15 -triphenyl phosphonium salt mixture with methylene chloride,

b) setting the pH of the water phase to about 3 to 4 with a mineral acid,

c) extracting with methylene chloride,

d) exchanging solvent with methanol by distilling off methylene chloride and introducing methanol, and

e) isolating the 9-(Z)-retinoic acid which crystallizes from the mixture.

11. The process according to claim 5 , wherein the isomeric mixture is comprised in a mother liquor obtained from the preparation of β-carotene, and the ratio of the (Z) to the (E) isomer in the mixture is about 2:1.

12. The process according to claim 1 , wherein the reaction temperature is from −15° C. to 15° C.

13. The process according to claim 1 , wherein the reaction occurs substantially free from the presence of light and oxygen.

Assignments (4)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 27, 2017
From: GLAXO GROUP LIMITED
To: BASILEA PHARMACEUTICA INTERNATIONAL LTD.
Reel/Frame 043414/0552 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 20, 2013
From: HOFFMANN-LA ROCHE INC.
To: GLAXO GROUP LIMITED
Reel/Frame 030053/0906 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 9, 2005
From: F.HOFFMAN-LA ROCHE AG
To: HOFFMAN-LA ROCHE INC.
Reel/Frame 016207/0848 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 9, 2005
From: SOUKUP, MILAN; THOMESSEN, ROLF
To: F. HOFFMANN-LA ROCHE AG
Reel/Frame 016208/0216 →
Priority Claims (1)
EP 03008020 · Apr 11, 2003 · regional
Continuity (1)
Related Publication 20040235951A1 · Nov 25, 2004